Nurse Practitioner, Psychiatric/Mental Health · Mexico, MO
NPI
1891365607
Since 2021
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
340 Kelley Pkwy
Mexico, MO, 65265
Phone (573) 582-1234
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$836K
3,057 prescriptions
Company payments, 2025
$1,826
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Tyva M Higgins prescribed most often to Medicare patients was Trazodone Hcl, with 195 prescriptions and refills. In total Tyva M Higgins wrote 3,057 Medicare prescriptions that cost $836K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Trazodone Hcl Generic | 195 | 247 | 43 | $1,981 |
| Buspirone Hcl Generic | 162 | 178 | 27 | $2,093 |
| Escitalopram Oxalate Generic | 162 | 188 | 20 | $957 |
| Hydroxyzine Hcl Generic | 155 | 174 | 38 | $2,840 |
| Duloxetine Hcl Generic | 151 | 195 | 26 | $2,809 |
| Quetiapine Fumarate Generic | 147 | 173 | 30 | $1,940 |
| Bupropion Xl Bupropion Hcl | 131 | 156 | 27 | $1,669 |
| Sertraline Hcl Generic | 125 | 138 | 24 | $915 |
| Risperidone Generic | 118 | 123 | 14 | $1,037 |
| Aripiprazole Generic | 107 | 126 | 20 | $7,629 |
| Topiramate Generic | 106 | 114 | 13 | $982 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 88 | 98 | Under 11 | $1,386 |
| Lithium Carbonate Generic | 88 | 114 | Under 11 | $488 |
| Vraylar Cariprazine Hcl | 78 | 88 | 15 | $116K |
| Lurasidone Hcl Generic | 76 | 78 | Under 11 | $7,637 |
Brand drugs: 384 claims; generic drugs: 2,673 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tyva M Higgins $1,826 ($1,826 in general payments such as food, travel and fees) from 13 companies. The largest payer was Neurocrine BioSciences, Inc. with $355.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 19 | $355 |
| Teva Pharmaceuticals USA, Inc. TEVA | 14 | $245 |
| Axsome Therapeutics, Inc. AXSM | 12 | $237 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $188 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $160 |
| Abbvie Inc. ABBV | 6 | $107 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $73.81 |
| Alkermes, Inc. ALKS | 4 | $72.32 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $63.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.